Table 1.
Patient characteristics.
| Patient | Gender | Age at diagnosis (y) | Living | Staging PET | SUV maximum staging | SUV maximum post-therapy | Treatment | Response by PET | Response by CT |
| 1 | M | 56 | Yes | No | NA | 0 | C | N | PR |
| 2 | M | 75 | No | Yes | 6.9 | 0 | C | N | PR |
| 3 | F | 63 | Yes | Yes | 2.57 | 1.11 | S,C | N | PR |
| 4 | F | 63 | Yes | Yes | 5.6 | 0 | C,R | N | SD |
| 5 | M | 77 | Yes | Yes | 11.54 | 0 | C,R | N | CR |
| 6 | M | 68 | No | No | NA | 0.6 | C,R | N | SD |
| 7 | F | 56 | No | No | NA | 2.34 | C,R | N | PR |
| 8 | F | 75 | Yes | Yes | 13.7 | 4.7 | C,R | N | CR |
| 9 | M | 84 | Yes | No | NA | 2.5 | C,R | N | NCR |
| 10 | M | 52 | No | No | NA | 0 | C,R | N | PR |
| 11 | M | 57 | No | No | NA | NA | C,R | N | PR |
| 12 | F | 64 | No | No | NA | 3.28 | C,R | P | SD |
| 13 | F | 65 | Yes | No | NA | 3.9 | C,R | P | PR |
| 14 | F | 60 | No | No | NA | 10.87 | C,R | P | PR |
| 15 | M | 70 | No | Yes | 0 | 8.46 | C,R | P | PR |
| 16 | F | 82 | No | No | NA | 2.25 | C,R | P | PR |
| 17 | F | 65 | Yes | Yes | 14.3 | 4.7 | C,R | P | PR |
| 18 | M | 44 | No | Yes | 5.7 | 5 | C | P | PD |
| 19 | F | 67 | Yes | No | NA | 23.5 | C,R | P | CR |
| 20 | F | 83 | Yes | No | NA | 3.9 | C,R | P | SD |
| 21 | F | 65 | No | No | NA | NA | C,R | P | PR |
| 22 | M | 67 | Yes | Yes | NA | NA | C | P | NCR |
CR, complete response; NA, not available; PET, positron emission tomography; PR, partial response; PD, progressive disease; NCR, near complete response; SD, stable disease; SUV, standard uptake values; C, chemotherapy: R, radiotherapy; S, surgery; P, positive; N, negative.